News
Supernus Pharmaceuticals has acquired Sage Therapeutics, strengthening its neuropsychiatry product portfolio.
A new report compiles the latest data and insight on scaling cell and gene therapy (CGT) effectively to improve patient access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback